Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 in CABG
NCT00966654Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Sep 2008
- Primary completion
- Aug 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Glucagon-like peptide 1(7-36)-amide in hyperglycemia, left ventricular dysfunction, sponsored by Johns Hopkins University. Started Sep 2008; status: terminated.
02
Drugs
Glucagon-like peptide 1(7-36)-amide
03
Conditions
hyperglycemialeft ventricular dysfunction
Beyond the preview
Go deeper on NCT00966654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966654.